ACGBY vs AZN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
ACGBY · AGRICULTURAL BK CH$21.87 ▲ 0.46%
AZN · AstraZeneca$186.43 ▼ 0.22%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- ACGBY +12.9%
- AZN +8.4%
Head to head
| Metric | ACGBY | AZN |
|---|---|---|
| Price | $21.87 | $186.43 |
| Change today | ▲ 0.46% | ▼ 0.22% |
| Market cap | $287.41B | $289.14B |
| Return, 3 months | +16.6% | +15.1% |
| Return, year to date | +21.3% | +3.1% |
| Return, 1 year | +14.5% | +12.1% |
| P/E (TTM) | 7.2 | 26.4 |
| P/B | 0.7 | 5.6 |
| P/E percentile vs own 5y | – | 21st |
| Dividend yield | 4.39% | 1.73% |
| Revenue growth (YoY, latest qtr) | – | +6.4% |
| Net profit growth (YoY) | – | +2.5% |
| Gross margin | – | 81.9% |
| Operating margin | – | 22.1% |
| Net margin | – | 17.0% |
| Return on equity | – | 22.0% |
| Analyst target vs. price | – | +17.8% |
| Analyst buy share | – | 86% |
| RSI (14) | 58 | 69 |
| 30-day volatility | 26.7% | 32.1% |
| Max drawdown, 1 year | -20.4% | -25.3% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- AZN is the largest of the group by market value.
- ACGBY has returned the most over the past year.
- ACGBY carries the lowest trailing P/E.
- ACGBY pays the highest dividend yield.
- ACGBY has been the calmest stock over the last 30 days.